BRIEF published on 09/16/2024 at 11:22, 1 year 6 months ago La Banque Palatine introduit Palatine Avenir 2030, un titre de créance à risque Investissement Marché Actions Banque Palatine Titre De Créance Risque De Capital
BRIEF published on 09/16/2024 at 11:22, 1 year 6 months ago Banque Palatine introduces Palatine Avenir 2030, a risky debt security Investment Stock Market Palatine Bank Debt Security Capital Risk
PRESS RELEASE published on 09/16/2024 at 11:17, 1 year 6 months ago Informations privilégiées / Autres communiqués La Banque Palatine lance Palatine Avenir 2030, un titre de créance à risque. Détails financiers et modalités de souscription inclus Souscription Banque Palatine Titre De Créance Palatine Avenir 2030 Risque
BRIEF published on 09/12/2024 at 10:50, 1 year 6 months ago Disponibilité des Final Terms de l'émission série 579 tranche 1 par la BFCM Investisseurs Final Terms Crédit Mutuel BFCM Émission Série 579
BRIEF published on 09/12/2024 at 10:50, 1 year 6 months ago Availability of the Final Terms of the 579 series issue tranche 1 by BFCM Investors Final Terms Crédit Mutuel BFCM Series 579 Broadcast
PRESS RELEASE published on 09/12/2024 at 10:45, 1 year 6 months ago BFCM Communiqué de mise à disposition des Final Terms de l’émission série 579 tranche 1 La Banque Fédérative du Crédit Mutuel communique les modalités de disponibilité des Final Terms de l’émission séries 579 tranche 1. Les documents sont accessibles sur le site de l’émetteur Final Terms Modalités Émission Document BFCM
BRIEF published on 09/12/2024 at 08:42, 1 year 6 months ago Sanofi, RadioMedix, and Orano Med Announce Exclusive Licensing Agreement for Radioligand Therapy Sanofi RadioMedix Orano Med AlphaMedix Neuroendocrine Tumors
BRIEF published on 09/12/2024 at 08:42, 1 year 6 months ago Sanofi, RadioMedix et Orano Med annoncent un accord de licence exclusif pour la thérapie par radioligand Sanofi Orano Med AlphaMedix Radio Médix Tumeurs Neuroendocrines
PRESS RELEASE published on 09/12/2024 at 08:37, 1 year 6 months ago Inside Information / Other news releases Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers Sanofi RadioMedix Orano Med Radioligand Medicine Rare Cancers
Published on 03/26/2026 at 23:00, 7 hours 19 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 8 hours 14 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 8 hours 19 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 8 hours 19 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 9 hours 19 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/27/2026 at 06:00, 19 minutes ago Fewer orders and lower sales - US tariffs, currency effects and cost pressure weigh on earnings
Published on 03/27/2026 at 05:15, 1 hour 4 minutes ago Neapco Holdings LLC Announces the Official Close of IFA Group Acquisition, Creating a Global Leader in Driveline Solutions
Published on 03/27/2026 at 04:00, 2 hours 19 minutes ago Tech-Driven Restoration: Saving the World's Critically Endangered White-headed Langur
Published on 03/26/2026 at 20:48, 9 hours 31 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 10 hours 59 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 18:17, 12 hours 2 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 12 hours 2 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 12 hours 19 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 12 hours 19 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité
